This editorial refers to ‘Balloon pulmonary angioplasty improves right atrial reservoir and conduit functions in chronic thromboembolic pulmonary hypertension’, by Y. Yamasaki et al., pp. 855–862.

There is growing awareness of the importance of the right atrial (RA)–right ventricular (RV) axis in pulmonary hypertension (PH). Invasively measured RA pressure, a surrogate marker of RV stiffness, has been a key predictor of outcome in multiple epidemiological studies of pulmonary arterial hypertension (PAH) across decades.1–3 This observation has not been made for any form of post-capillary PH4 or borderline PH,5 suggesting an exclusive functional importance of the RA in pre-capillary PH.

The manuscript by Yamasaki et al.6 features novel work as it focuses on right atrial function predicting reverse remodelling in chronic thrombo-embolic pulmonary hypertension (CTEPH). The authors performed cardiac magnetic resonance imaging (CMRI) and right heart catheterization in 29 CTEPH patients prior to and after percutaneous balloon pulmonary angioplasty (BPA) in Japan, where BPA is the primary treatment option for CTEPH. RA phasic function was studied with a CMRI-based feature-tracking algorithm. As a secondary finding of this manuscript, authors obtained excellent BPA results, with a mean pulmonary artery pressure declining from 38.4 ± 10.3 before BPA to 24.4 ± 4.2 mmHg after BPA. Six-minute walk distance improved from 382 ± 87 to 451 ± 94 m, and functional class was significantly improved. BPA has been introduced in Europe after refinement of the original technique7 by Japanese interventionists,8 providing a new therapeutic option for CTEPH patients who are not suitable candidates for pulmonary endarterectomy (PEA). Although Japanese CTEPH may be different from European CTEPH,9 authors’ results resemble haemodynamic outcomes achieved by PEA. To study reverse right heart remodelling in the absence of surgical trauma such as PEA, right atrial strain was measured in the current study and was significantly improved after BPA rising from 32.4% to 42.7%, which is near-normalized when compared with 123 normal individuals in whom mean RA reservoir strain was 44.9 ± 11.6%.10 Yamasaki et al. observed improvements in RA reservoir and conduit functions after BPA and identified them as sensitive non-invasive markers of reverse vascular remodelling and decreased RV afterload, illustrating that changes of RA strain correlate well with changes of steady components of RV afterload (e.g. change in pulmonary vascular resistance (PVR)). Presumably changes of RA strain will also associate with changes of pulsatile components of afterload, e.g., pulmonary artery compliance, which were, however, not shown in the present work. Correlations were also found with BNP levels, the key biomarker for RV function.

There is accumulating evidence that right atrial imaging, including its size, is of unique importance. The RA is in continuity with the inferior vena cava (IVC), and based on RA diameter and respiratory variation of IVC diameter PAH may be diagnosed.11 In the DETECT study that was designed for early detection of PAH in scleroderma (SSc) patients, most of the SSc patients with newly diagnosed PAH presented with PVR values <3 WU which is below the current revised threshold of PVR for PAH,12 but RA size was already mildly increased.13 The normal direction of flow towards the RV is determined by small pressure differences between central venous- and RA pressure,14 by RA contraction and the resistance of the RV to diastolic filling (RV end-diastolic stiffness). Advances in CMRI and speckle-tracking echocardiography have led us to understand three functions of the RA: reservoir, (passive) conduit, and (active) contractile. While reservoir and conduit function are captured by peak RA longitudinal strain rate (LSR) and early RA LSR, respectively, RA active contractile strain is measured by RA late LSR. Recent data have demonstrated that RA peak LSR is less of an estimate of RA pressure,15,16 than it is an estimate of RV diastolic function reflected in RV end-diastolic pressure and end-diastolic elastance, and clinical worsening.17 A recent study combined CMRI and conductance catheterization to examine RV functional correlates of RA strain including RV-pulmonary vascular coupling in severe PAH.18 The term coupling defines the energy transfer from the RV to the pulmonary circulation and can be assessed by the ratio between end-systolic elastance (Ees) and arterial elastance (Ea). CMRI-derived right atrial (RA) phasic function was associated primarily with RV diastolic function, and may be an estimate of RV-PA coupling in those patients who have not fallen below the point of uncoupling at an Ees/Ea of 0.805 as was the case in this study.18

Impaired RA reservoir function (low peak LSR) is correlated with RA size, inferior vena cava (IVC) diameter,18 and backward flow in the IVC.19 In addition to tricuspid regurgitation as one of the signs of poor RA–RV coupling, atrial regurgitation occurs mostly during atrial contraction and contributes independently to backwards venous flow, systemic congestion, and subsequent aggravation of clinical signs of right heart failure.19 As the authors recognize, there is more work to do to decipher the role of vena cava compliance and RA function to better understand IVC-RA coupling, and its potential improvement after BPA, or any other relief of RV afterload.

In summary, data are accumulating that RA strain may be an early and sensitive surrogate for positive or negative right heart remodelling, and coupling. Assessment of RA function delivers sensitive data, and should be part of the management and follow-up of patients with PAH.

Conflict of interest: none declared.

References

1

D’Alonzo
GE
,
Barst
RJ
,
Ayres
SM
,
Bergofsky
EH
,
Brundage
BH
,
Detre
KM
et al.
Survival in patients with primary pulmonary hypertension. Results from a National Prospective Registry
.
Ann Internal Med
1991
;
115
:
343
9
.

2

Benza
RL
,
Miller
DP
,
Gomberg-Maitland
M
,
Frantz
RP
,
Foreman
AJ
,
Coffey
CS
et al.
Predicting survival in pulmonary arterial hypertension: insights from the Registry to Evaluate Early and Long-Term Pulmonary Arterial Hypertension Disease Management (REVEAL
).
Circulation
2010
;
122
:
164
72
.

3

Weatherald
J
,
Boucly
A
,
Chemla
D
,
Savale
L
,
Peng
M
,
Jevnikar
M
et al.
Prognostic value of follow-up hemodynamic variables after initial management in pulmonary arterial hypertension
.
Circulation
2018
;
137
:
693
704
.

4

Vanderpool
RR
,
Saul
M
,
Nouraie
M
,
Gladwin
MT
,
Simon
MA.
Association between hemodynamic markers of pulmonary hypertension and outcomes in heart failure with preserved ejection fraction
.
JAMA Cardiol
2018
;
3
:
298
306
.

5

Maron
BA
,
Hess
E
,
Maddox
TM
,
Opotowsky
AR
,
Tedford
RJ
,
Lahm
T
et al.
Association of borderline pulmonary hypertension with mortality and hospitalization in a large patient cohort: insights from the veterans affairs clinical assessment, reporting, and tracking program
.
Circulation
2016
;
133
:
1240
8
.

6

Yamasaki
Y
,
Abe
K
,
Kamitani
T
,
Hosokawa
K
,
Kawakubo
M
,
Sagiyama
K
et al.
Balloon pulmonary angioplasty improves right atrial reservoir and conduit functions in chronic thromboembolic pulmonary hypertension
.
Eur Heart J –Cardiocasc Imaging
2020
;
21
:855–62.

7

Feinstein
JA
,
Goldhaber
SZ
,
Lock
JE
,
Ferndandes
SM
,
Landzberg
MJ.
Balloon pulmonary angioplasty for treatment of chronic thromboembolic pulmonary hypertension
.
Circulation
2001
;
103
:
10
3
.

8

Mizoguchi
H
,
Ogawa
A
,
Munemasa
M
,
Mikouchi
H
,
Ito
H
,
Matsubara
H.
Refined balloon pulmonary angioplasty for inoperable patients with chronic thromboembolic pulmonary hypertension
.
Circ Cardiovasc Interv
2012
;
5
:
748
55
.

9

Chausheva
S
,
Naito
A
,
Ogawa
A
,
Seidl
V
,
Winter
MP
,
Sharma
S
et al.
Chronic thromboembolic pulmonary hypertension in Austria and Japan
.
J Thorac Cardiovasc Surg
2019
;
158
:
604
14.e2
.

10

Brand
A
,
Bathe
M
,
Hubscher
A
,
Baldenhofer
G
,
Hattasch
R
,
Seeland
U
et al.
Normative reference data, determinants, and clinical implications of right atrial reservoir function in women assessed by 2D speckle-tracking echocardiography
.
Echocardiography (Mount Kisco, NY)
2018
;
35
:
1542
9
.

11

Lang
RM
,
Badano
LP
,
Mor-Avi
V
,
Afilalo
J
,
Armstrong
A
,
Ernande
L
et al.
Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
.
Eur Heart J Cardiovasc Imaging
2015
;
16
:
233
70
.

12

Simonneau
G
,
Montani
D
,
Celermajer
DS
,
Denton
CP
,
Gatzoulis
MA
,
Krowka
M
et al.
Haemodynamic definitions and updated clinical classification of pulmonary hypertension
.
Eur Respir J
2019
;
53
:
1801913
.

13

Coghlan
JG
,
Denton
CP
,
Grunig
E
,
Bonderman
D
,
Distler
O
,
Khanna
D
et al. ; on behalf of the DETECT study group.
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
.
Ann Rheum Dis
2014
;
73
:
1340
9
.

14

Wexler
L
,
Bergel
DH
,
Gabe
IT
,
Makin
GS
,
Mills
CJ.
Velocity of blood flow in normal human venae cavae
.
Circ Res
1968
;
23
:
349
59
.

15

Querejeta Roca
G
,
Campbell
P
,
Claggett
B
,
Solomon
SD
,
Shah
AM.
Right atrial function in pulmonary arterial hypertension
.
Circ Cardiovasc Imaging
2015
;
8
:
e003521
.

16

Wright
LM
,
Dwyer
N
,
Wahi
S
,
Marwick
TH.
Association with right atrial strain with right atrial pressure: an invasive validation study
.
Int J Cardiovasc Imaging
2018
;
34
:
1541
8
.

17

Richter
MJ
,
Fortuni
F
,
Wiegand
MA
,
Dalmer
A
,
Vanderpool
R
,
Ghofrani
HA
et al.
Association of right atrial conduit phase with right ventricular lusitropic function in pulmonary hypertension
.
Int J Cardiovasc Imaging
2020
;
36
:
633
42
.

18

Tello
K
,
Dalmer
A
,
Vanderpool
R
,
Ghofrani
HA
,
Naeije
R
,
Roller
F
et al.
Right ventricular function correlates of right atrial strain in pulmonary hypertension: a combined cardiac magnetic resonance and conductance catheter study
.
Am J Physiol
2020
;
318
:
H156
h64
.

19

Marcus
JT
,
Westerhof
BE
,
Groeneveldt
JA
,
Bogaard
HJ
,
de Man
FS
,
Vonk Noordegraaf
A.
Vonk Noordegraaf A. Vena cava backflow and right ventricular stiffness in pulmonary arterial hypertension
.
Eur Respir J
2019
;
54
:
1900625
.

This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://dbpia.nl.go.kr/journals/pages/open_access/funder_policies/chorus/standard_publication_model)